Avastin 'not approved' for breast cancers24th February 2011
The National Institute for health and Clinical Excellence (NICE) has ruled that the drug Avastin should not be used to treat secondary breast cancers.
The NHS drugs advisory body for NHS in England and Wales said there was insufficient evidence that the drug prolonged life, though breast cancer charities have said that they are disappointed by the decision. Avastin, also known as bevacizumab, works by starving cancer cells of a blood supply and is designed to be used in conjunction with another chemotherapy drug, paclitaxel.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Avastin 'not approved' for breast cancers
Author: Mark Nicholls
Article Id: 17679
Date Added: 24th Feb 2011